Results 71 to 80 of about 30,428 (253)
Thymectomy in ocular myasthenia gravis—prognosis and risk factors analysis
Background Several retrospective studies have identified risk factors associated with ocular myasthenia gravis (OMG) generalization in non-surgical patients. However, the outcomes of OMG after thymectomy have not been investigated fully. This study aimed
Jinwei Zhang+6 more
doaj +1 more source
Thymectomy in Juvenile Myasthenia Gravis Is Safe Regarding Long Term Immunological Effects
Thymectomy is an established treatment in adult MG and also recommended for the treatment of post-pubertal onset juvenile MG. Whether the youngest children should be thymectomized is still debated.
Trine H. Popperud+9 more
doaj +1 more source
Subxiphoid and subcostal arch "Three ports" thoracoscopic extended thymectomy for myasthenia gravis.
Background The approaches to thoracoscopic thymectomy in myasthenia gravis (MG) are debatable. We developed a novel approach via subxiphoid and subcostal arch, with a significantly shorter duration of operation and hospital stay, less estimated blood ...
Q. Lu+7 more
semanticscholar +1 more source
Thymic hyperplasia as a rare etiology of pure red cell aplasia: A case report [PDF]
Introduction. Thymic hyperplasia is a rare condition caused by an increase in cellular thymic mass and, in some cases, is associated with autoimmune diseases, such as pure red cell aplasia (PRCA).
Arsenović Isidora+6 more
doaj +1 more source
Background Myasthenia gravis (MG) is a rare neuromuscular disorder. Symptoms can range from ptosis only to life threatening myasthenic crisis. Thymectomy is recommended for anti-acetylcholine receptor-antibody positive patients with early-onset MG. Here,
Hruy Menghesha+12 more
doaj +1 more source
BackgroundTo improve the preoperative diagnostic accuracy and reduce the non-therapeutic thymectomy rate, we established a comprehensive predictive nomogram based on radiomics data and computed tomography (CT) features and further explored its potential ...
Zhou Zhou+5 more
doaj +1 more source
Handling rescue therapy in myasthenia gravis clinical trials: why it matters and why you should care
Abstract Myasthenia gravis (MG) clinical trials typically allow rescue therapy during follow‐up in the event of marked worsening of MG symptoms. Failure to appropriately address rescue therapy in defining treatment effects and planning statistical analyses may yield biased estimates, increase false positive rates, or decrease statistical power – all of
Justin M. Leach+3 more
wiley +1 more source
Thymoma with Myasthenia Gravis in Adolescent [PDF]
Thymomas are exceedingly rare in the first 20 years of life, Thymic lesions comprise approximately 2–3% of all pediatric mediastinal tumors and include thymic cysts, hyperplasia, carcinoma, and thymomas.
Balaiah, K+3 more
core +1 more source
Pure Red Cell Aplasia Associated with Thymolipoma: Complete Anaemia Resolution following Thymectomy
Pure red cell aplasia is an uncommon cause of anaemia rarely associated with thymoma. A combination of immunosuppressive therapy and thymectomy offers a potential cure. Thymectomy alone rarely results in anaemia resolution.
David Ferreira+3 more
doaj +1 more source
ABSTRACT Introduction Myasthenia gravis (MG) is an autoimmune disease presenting typically at an earlier age in females compared to males. However, whether sex affects the diagnostic delay and clinical course of MG has not been extensively explored in systematic cohorts.
Chris Myllynen+3 more
wiley +1 more source